chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a female consumer stating that she refused to give her children the MMR II because three male children that she known developed autism immediately after they were given the shot. One case concerned a 2 year old male pt who was vaccinated with a dose of MMR II vaccine live. It was unknown if there were any concomitant medications, or if the pt had any past medical history or allergies. Subsequently, the pt developed autism. The three boys were six (WAES0206USA01723), four (WAS0206USA01826) and two years of age. It was reported that they had always been very cognitive and always made eye contact. The reporter noted that "ever since they were given the shot, they developed autism." The pt's autism persisted. It was unknown if medical attention was sought. No other info was provided. Additional info has been requested. Follow up info received from a registered nurse indicated that she did not recall any male children in her practice that had received the MMR II vaccination and then were diagnosed with autism. She could not provide any additional info. *Add'l follow-up info received indicated that the MD's office was "unable to assist at this time due to no PT name." Upon internal review, autism was determined to be an other important medical event (OMIC). No further info is available.
I initially had a fever, severe brain fog and body aches for week after 1st vaccination. After second developed focus problems and chronic fatigue, neurological itching, pain, numbness, headaches, spine pain, joint pain, constipation, stomach motility problems, stomach ulcer, acid reflux, chronic dry mouth with ulcers, Sjögren syndrome, small fiber neuropathy with widespread paresthesias, dysautonomia, fibromyalgia, sucrose deficiency, mast cell activation syndrome, symptoms were significant within one month of injection and still seeing specialists constantly and further testing and medication trials and my life is significantly impacted when I was fine prior to vaccination very healthy and active.
Employee given 5th HEP B today within 10 min of injection being given in (R)D. Employee noted back teeth became numb on both sides upper & lower, as if given novocaine @ the dentist office. Numbness traveled to (R) cheek, sinus & eyelid. No visible drooping to (R) side.
chills; fever; headache; muscle/body aches; fatigue; nausea; loose stool; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches), FATIGUE (fatigue), NAUSEA (nausea), DIARRHOEA (loose stool) and ARTHRALGIA (joint pain). At the time of the report, CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle/body aches), FATIGUE (fatigue), NAUSEA (nausea), DIARRHOEA (loose stool) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient came and informed that she an adversed reaction with Fluad Quadrivalent which was given on 10/15/20.  There was redness on the injection site at her left deltoid on the night of 10/15/20.   She had fever, chills, and pain on her upper left arm and doubled in size.   She went to Urgent Care on 10/17/20 and was diagnosed with cellulitis.  Her temporal temperature was 97.7 F and slightly elevated BP 139/82.  The swelling had subsided with some redness on the inner left arm.  She was prescribed Keflex 500mg TID at Pharmacy.
This spontaneous report as received from a pharmacist refers to two unspecified patients. On unknown dates, the patients were vaccinated with PNEUMOVAX 23 (lot # J008799, expiration date 16-APR-2015). The two unspecified patients developed cellulitis after vaccinated with PNEUMOVAX 23. The outcome of cellulitis was unknown. The pharmacist requested a lot check for J008799. This is one of several reports from same source. Additional information has been requested.
2AUG96 115PM had redness & induration approx 50x60mm lt deltoid;
3/22/21: Pain and swelling at injection site around 4p. Chills, nausea and extreme exhaustion around 5p. Just got in the bed to sleep off the symptoms about 6:15p.  3/23/21: Pain and swelling at injection site persisted. Also had pain under left arm that radiated to left breast, down left side, up the neck and upper left back as day progressed. Went to take a shower around 4:30p and noticed the lump/swelling under left arm, beside left breast. Area of the lump was tender to the touch. Went to Patient first to get checked out and was prescribed steroids to reduce the pain, swelling and inflammation.
2 experiences of 4 hrs of crying leg warm, red no significant fever as pt was given APAP q 4 hrs for the first 24 hrs p/immun given;
No adverse effects; the vaccine was inadvertently reconstituted with the incorrect diluent; the vaccine was inadvertently reconstituted with the incorrect diluent; This spontaneous report was received from a medical assistant and refers to a 8-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 19-AUG-2019, the patient was vaccinated with the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot# S006646, expiration date 05-MAR-2021, exact dose and route of administration were not reported) and varicella virus vaccine live (oka/merck)(VARIVAX) (lot R035221, expiration date 04-DEC-2020, exact dose and route of administration were not reported), both for prophylaxis. One of the administered vaccines was reconstituted with sterile diluent (MENCYW 135 liquid) (lot AMXA072A, expiration date ??-MAR-2021), which was the diluent for meningococcal ACYW conj vaccine (CRM197) (MENVEO) and the second was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot S008564, expiration date 05-AUG-2021). It was unknown by reporter which vaccine was inadvertently reconstituted with the incorrect sterile diluent. No adverse effects were reported.
covid rash on right arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (covid rash on right arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (covid rash on right arm). At the time of the report, RASH (covid rash on right arm) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported
He received FLUARIX QUAD 2015-2016 vaccine in 9/10/15, We did not realize this and he got FLUZONE HIGH DOSE 2015-16 vaccine today 1/20/2016.
Caller states that she is a 21 year old female who got the Moderna Vaccine for COVID 19 yesterday and started having a fever at 2 am, and it went away this evening with acetaminophen, but she is also having some chest pain that almost feels like something is stuck this evening.  Advised that chest pain is a concerning emergency and she should have herself seen.  She feels like she will wait and see, may just be heart burn, but she understands our recommendation, may go in.  Reviewed ADE questions with her.  She gives permission for a follow up call tomorrow.   5/3-f/u call made; caller reports no futher chest pain; it resolved on it's own last night
facial swelling post receiving a Covid vaccine/chin [is] uncomfortable/swelling in these areas; swelling/hard and lumpy; This is a spontaneous report from a non-contactable other- healthcare professional (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration as dose number unknown, single for COVID-19 immunization; hyaluronic acid (JUVEDERM), into the pre-jowl area, route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient's medical history was not reported. Concomitant medication included thyroid (ARMOUR THYROID), 180 mg and fortnightly injections of TNF therapy taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the patient presented with swelling in these areas (pre-jowl area)3 weeks post COVID-19 vaccine. The cheeks were said to be not too bad but the chin [was] uncomfortable and persistent. Treatment started with antihistamines. The area then became lumpy so treatment with Prednisolone started. Patient was still hard and lumpy. The clinical outcome for the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a nurse via company representative refers to 11 or 12 year old female patient. No medical history was reported. On an unknown date, the patient was vaccinated with her second or third dose of GARDASIL lot # K005881, dose 0.5 ml, intramuscular. Other suspect therapy included intranasal FLUMIST which was co-administered on the same date. The patient experienced seizure, with full body shaking and loss of consciousness after she received the dose of GARDASIL. The patient recovered spontaneously in the office on the same day without any intervention. When the patient regained consciousness, she did not have any memory of the event. The reporter causality assessment was not provided. Upon internal review, the event of seizure was determined to be medically significant. Additional information has been requested.
feel really bad; really sick; really bad heart pain; palpitations/heart racing on my chest/heart beating on my chest; out of breath as well; headaches; running a fever; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feel really bad), ILLNESS (really sick), CHEST PAIN (really bad heart pain), PALPITATIONS (palpitations/heart racing on my chest/heart beating on my chest) and DYSPNOEA (out of breath as well) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Atrial fibrillation and Cardiomyopathy. Concomitant products included METOPROLOL, ATORVASTATIN and APIXABAN (ELIQUIS) for an unknown indication.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, the patient experienced FEELING ABNORMAL (feel really bad). In September 2021, the patient experienced ILLNESS (really sick), CHEST PAIN (really bad heart pain), PALPITATIONS (palpitations/heart racing on my chest/heart beating on my chest), DYSPNOEA (out of breath as well), HEADACHE (headaches), PYREXIA (running a fever) and DIZZINESS (dizzy). At the time of the report, FEELING ABNORMAL (feel really bad), ILLNESS (really sick), CHEST PAIN (really bad heart pain), PALPITATIONS (palpitations/heart racing on my chest/heart beating on my chest), DYSPNOEA (out of breath as well), HEADACHE (headaches), PYREXIA (running a fever) and DIZZINESS (dizzy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medication was given for events. Reportedly, Patient hasn't gone to the doctor yet. Patient hasn't had covid-19 before yet.   This case was linked to MOD-2021-416944 (Patient Link).
Tingling throughout body, facial edema (cheeks) with redness noted, throat tightening, difficulty breathing
Rapid heart beat with elevated blood pressure and pulse. Returned to acceptable level after 1 hour.
tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced COVID-19 (tested positive for COVID-19). At the time of the report, COVID-19 (tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Headache, brain fog, arm feels hot Narrative: Received covid vaccine today and feels Brain Fog, HA, arm feels hot left work for the rest of the day per supervisor
patient with history of childhood chickenpox received a Shingrix zoster vaccination. 3 days after vaccination patient reported itchy rash on both legs, buttocks, and left hand w/ some swelling. Patient denied SOB or difficulty breathing, denied fever. MD was notified. Patient will not complete the series
My menstrual cycle has always been very normal. The last menstrual cycle before the booster shot was on 10/26. My cycle started again exactly one week after I received the vaccine on 11/11 and now again a week later, 11/18.
Sore arm; This non-serious case was reported by a consumer via sales rep and described the occurrence of pain in arm in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE for prophylaxis.   On 26-SEP-2023, the patient received the 1st dose of Arexvy (unknown arm). On an unknown date, the patient received INFLUENZA VACCINE. In SEP-2023, an unknown time after receiving Arexvy, the patient experienced pain in arm (Verbatim: Sore arm).  The outcome of the pain in arm was not reported.   The reporter considered the pain in arm to be related to Arexvy.     The company considered the pain in arm to be related to Arexvy.   Additional Information: GSK Receipt date: 27-SEP-2023 The patient stated that Flu vaccine was administered at the same visit and her arm hurts otherwise no other side effects. It was unknown if the reporter considered the pain in arm to be related to Flu vaccine.    The reporter consent to follow up.
This vaccine was given after BUD. Parent  did not report any adverse reaction after  vaccine was received.
Swelling on lip and cheek, patient self administered Benadryl and symptoms resolved. Than on 2/16/17 at aprox 1800, patient reports he had hives on abdomen. Patient self administered Benadryl and symptoms resolved.
Received 1st flu shot in life. Was told to sit within eyesight of the nurse. Pt. began having trouble breathing and felt throat starting to close. Nurse called for help from pharmacy. Pt. given Epi 0.3 cc SQ at injection site - Rt. arm and 0.2cc in Lt. arm. Pt. started feeling better. 911 called. Transported by EMS to hospital.
Large red area at injection site (left arm), itching & tenderness to touch, red rash in armpit with itching.  For 2-3 days before the redness I noticed tenderness & itching at the injection site & armpit.  Only other symptom is feeling very tired.  I contacted my doctor & sent her photos.  She agreed it was Covid arm & told me to contact this site & to let her know if I was getting better or not.
On 3/28/2022 the Department of Health identified this individual as a recipient of an expired dose of Pfizer Covid vaccine. The expiration date had been found to be miscalculated. The individual has/will be notified by telephone as well as by letter of the event and offered an additional dose of Pfizer Covid vaccine to ensure effectiveness. This additional dose of Pfizer Covid vaccine has not yet been administered to the individual.   Dose administered on 3/11/2022 was a booster dose following a Janssen Covid vaccine.
Patient awoke the following morning (12 hours later) itching and covered with a very itchy red rash that extended across the back of the neck and over the tops of her feet and hands.
Severe Headache, could not tolerate light, dehydrated, aching joints, cramping of muscles, at times difficulty breathing. Placed two warm water humidifiers near bed and drank lots of water. It took 24 hours to recover.
Severe diarrhea causing signs of dehydration. Went to ER. Received IVF bolus, then discharged.
Rash on injection sight of injection 8 days after the shot. Red spots on hands and feet. Itching on all of these sights.
Within one hour of receiving the vaccine pt experienced body aches and nausea. Took Motrin and felt better within 2 hours.
This case was reported by a pharmacist via call center representative and described the occurrence of Bone injury in a 79-year-old female patient who received SHINGRIX (batch number 4LP5Y, expiry date 27th February 2021) for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced accidental underdose. On an unknown date, the outcome of the accidental underdose was unknown. Additional details reported as follows: The healthcare professional stated that another pharmacist was giving a patient second dose and for some reason the needle and plunger would not work and patient only got 0.2 mL instead of 0.5 mL, which led to accidental underdose. The reporter's contact details were updated. In Aug 2018, the patient received SHINGRIX intramuscularly. The patient experienced bone injury after 1st dose. The pharmacist, who gave the vaccine, gave it only 0.2 ml. He does not know if he hit the bone or if the syringe was defective. The patient come back in the following week on 15th August 2018, and received the corrective dose (0.5 ml), without adverse effects. The VAERS details were updated.
Hematuria/blood in my urine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HAEMATURIA (Hematuria/blood in my urine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HAEMATURIA (Hematuria/blood in my urine). At the time of the report, HAEMATURIA (Hematuria/blood in my urine) outcome was unknown.
Pain at site of shot.  Hot flashes, chills.  Before bed got real hot from waste up.  Muscle spasms. twitchs at shot site.  Light headed, dizzy, shortness of breath.  Shot should have been 2nd dose of pfizer. Pharmacist called the next day and told me to remove Janssen sticker from covid shot record card and said to write in pfizer info.
Presented to the emergency room with a chief complaint of weakness and tingling in the extremities for 3 days.  It started with tingling and numbness in his hands, followed by foot.  It involves all his fingers up to just below shoulder, and also his toes.  Feels that he is in balance.  He also complains of mild headache.  Denies any history of dysarthria, visual changes.  He had a recent vaccination a couple of weeks ago, prior to his symptoms.  No history of any upper respiratory tract infection. 1.  Guillain-Barre syndrome. His EMG was abnormal, consistent with demyelinating neuropathy.  He had a spinal tap, which revealed elevated protein.  He was started on plasmapheresis on 10/27/07. He had a pleural catheter placed by Nephrology.  So far, he received 5 plasmapheresis.  His symptoms are better.  He is actively participating in physical therapy. 2.  Hypertension.  His blood pressure was elevated in the hospital.  He was started on Norvasc.  Will continue Norvasc 10 mg p.o. daily.  Will avoid ACE inhibitors as he is on plasmapheresis. 3.  Nonobstructive 10-mm left renal mid pole calculus. Asymptomatic. 4.  GERD.  He was started on Prilosec. 1/18/08-records received for DOS 10/24-11/2/07-DC DX: Guillain-Barre syndrome. Hypertension. GERD, nonobstructive 10-mm left renal mid pole calculus. Presented to ER with C/O weakness and tingling in extremities for 3 days. Tingling began then followed with numbness in hands, followed by foot. Involves all his fingers and up to shoulders and toes. Headache. Treated with plasmapheresis. Transferred to inpatient rehab.  Ongoing paresthesias. Significant weakness initially, requiring hospitalization and several months of therapy and time off work. Now recovering from GUILLAIN-BARRE syndrome and effects. Now complete recovery except for mild fatuge and paresthesis.
supraclavicular lymphadenopathy - noticed swelling on both sides of body just above clavicles 2 days after injection. more pronounced on left side. 4 days after injection much more pronounced. no pain. tender to the touch.  nothing else in daily life has altered other than injection.
Pt states she had an area on her thigh that was itchy. No rash no fever. Kept itching so she went to her dr 12/30/13 and he said it was shingles as a result of varicella vaccine given 7 years post stem cell transplant. Pt treated with acyclovir.
Severe vertigo, dizziness, and high blood pressure spikes as high as 220/119 which  lasted for one day.   However, it took me 3 days to completely recover from the woozy feeling and regain  balance.  Blood pressure still high after 3 days 135/94, up from my  usual B.P.  with medication of about 126/84.
Pain kind of hurt; Watery Nose; I came down with Fever; Watery eyes; Burning throat; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Apr2021 (Lot Number: SW0172) as SINGLE DOSE for COVID-19 immunization. The patient's medical history and the concomitant medications were not reported. On 30Apr2021, the patient came down with a fever and watery eyes, burning throat and just had sinus passageway and then on 01May2021, patient woke up with a fever again and had the pain kind of hurt, and still had fever and watery nose the whole day.That's all the problem patient had. The patient asked whether he/she should get a COVID test or it was normal. The outcome was reported as not recovered for fever and runny nose and unknown for rest of the events at the time of reporting.  No follow-up attempts are needed. No further information is expected.
pain, swelling, redness, itching, indurated @ site of inj;Motrin & ice to site;